Related Experiment Video
Updated: Nov 11, 2025
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.4K
Confident identification of subgroups from SNP testing in RCTs with binary outcomes
Yue Wei1, Xinjun Wang1, Emily Y Chew2
1Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
Biometrical Journal. Biometrische Zeitschrift
|March 22, 2021
Summary
This study introduces a new method to find genetic subgroups with better treatment results in clinical trials for age-related macular degeneration (AMD). The method successfully identified gene regions linked to reduced AMD progression.
Area of Science:
- Genetics
- Ophthalmology
- Pharmacogenomics
Background:
- Genotype information is increasingly used in clinical trials for personalized medicine.
- Identifying single nucleotide polymorphisms (SNPs) for differential treatment efficacy in binary outcomes is challenging.
- Traditional association tests are insufficient for complex genetic analyses in randomized controlled trials (RCTs).
Purpose of the Study:
- To develop a novel SNP-testing procedure for binary clinical outcomes in RCTs.
- To identify genetic subgroups with enhanced treatment efficacy for age-related macular degeneration (AMD).
- To rigorously control for multiplicity in genetic association testing.
Main Methods:
- Proposed a novel SNP-testing procedure using four contrasts to assess relative risk.
- Developed a method to control for within- and across-SNP multiplicity.
- Evaluated the method's performance using chromosome-wide simulations with real genotype data.
Main Results:
- The proposed method successfully identified multiple gene regions associated with enhanced treatment efficacy in an AMD trial.
- Simulations confirmed the method's performance and provided practical recommendations.
- Demonstrated the ability to infer genetic subgroups with improved clinical outcomes.
Conclusions:
- The novel SNP-testing procedure is effective for identifying genetic subgroups with differential treatment efficacy in binary outcome trials.
- This approach advances personalized medicine by enabling the discovery of genotype-specific treatment benefits.
- The method provides a robust framework for genome-wide SNP testing in complex diseases like AMD.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
14.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.9K
01:13Randomized Experiments
8.5K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.5K
02:26Comparing Copy Number Variations and SNPs
18.3K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.3K
01:20Comparing the Survival Analysis of Two or More Groups
388
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
388
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
244
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
244
01:05Single Nucleotide Polymorphisms-SNPs
17.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K